Literature DB >> 8064664

Unexpected neurotoxicity in dogs receiving a cyclophosphamide, dactinomycin, and 5-fluorouracil chemotherapy protocol.

A S Hammer1, M A Carothers, C L Harris, D A O'Keefe, R D Ayl, J L Peterson, K A Shank, C G Couto.   

Abstract

An inexpensive combination chemotherapy protocol containing cyclophosphamide, dactinomycin, and 5-fluorouracil was evaluated in dogs with carcinomas. Fifteen dogs were entered in this study, and there were 1 complete response and 2 partial responses among 12 evaluable dogs. However, 6 of 15 dogs (40%) developed neurotoxicity. The neurotoxicity of this protocol was compared with a previous 5-fluorouracil-containing protocol and found to be significantly higher. Due to the unacceptably high rate of neurotoxicity, this protocol cannot be recommended for use in dogs with cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064664     DOI: 10.1111/j.1939-1676.1994.tb03225.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  1 in total

1.  Pharmacokinetic analysis of doxifluridine and its metabolites, 5-fluorouracil and 5-fluorouridine, after oral administration in beagle dogs.

Authors:  In-Hwan Baek; Byung-Yo Lee; Min-Soo Kim; Kwang-Il Kwon
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-07       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.